A study assessing factors that may determine a commercial health plan’s likelihood of covering a biosimilar found that biosimilars that are cancer therapies, used to treat children, indicated for highly prevalent conditions, or only competing against the originator were more likely to have coverage restrictions.
Although many topical or systemic antibiotics exist to treat acne vulgaris, the common inflammatory skin disease is not fully treatable.
A recent study found that the majority of interventional phase 3 trials lacked a clear definition of high-risk multiple myeloma, and many patients were missing important data for risk stratification.
The systematic review and meta-analysis showed no correlation between epilepsy surgery and intelligence quotient (IQ) or quality of life (QOL) among younger patients with facial cortical dysplasia (FCD) and long-term epilepsy-associated tumors (LEAT).
Little is known about the risk of bleeding in patients with bleeding disorders who undergo major surgeries or outcomes for those managed perioperatively at hemophilia treatment centers.
A study explored outcomes among patients living with newly diagnosed eosinophilic esophagitis (EoE) who demonstrated lack of histological response following proton pump inhibitor (PPI) treatment.
For patients with aspirin-exacerbated respiratory disease (AERD), omalizumab significantly reduced their symptoms, according to one study.
The use of active surveillance for indolent prostate cancer cases continues to rise in the United States, but rates of use are lower in minority groups, low-income groups, and patients in rural areas, a recent study found.
A survey of health care leaders presented during the HIMSS Global Health Conference & Exhibition found most weren’t very satisfied with the technology they are offering patients.
Globally, people lost confidence in the importance of routine childhood vaccines against lethal diseases like measles and polio, a survey finds; advocates say that the proposed price of about $50 a kit for naloxone could be too expensive; Bipartisan Senate legislation introduced this week would cap insulin at $35 per month for those with private insurance.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The investigators of this study wanted to know if hospitals that cared for a high proportion of Black patients delivered care for heart failure (HF) that differed in quality from that provided by other hospitals.
Individuals with severe type 2 asthma and chronic rhinosinusitis with nasal polyps may benefit from the biologic treatment, dupilumab.
In several abstracts presented at this year's American Academy of Neurology Annual Meeting, Mitzi Joi Williams, MD, FAAN, Joi Life Wellness Neurology Clinic, explores multiple sclerosis–related outcomes in diverse patient populations.
A recent study observed that poor sleep quality and having very little or a lot of sleep were associated with greater likelihood of having had COVID-19 in the past, while poor sleep quality was linked with an increased requirement of hospitalization for severe COVID-19.
The FDA has approved polatuzumab vedotin-piiq plus rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP) for certain patients with treatment-naive diffuse large B-cell lymphoma.
Although children with type 1 diabetes (T1D) are slightly more likely to experience long-term educational underachievement than their peers without T1D, those who also have a psychiatric disorder have significantly lower odds of achieving educational milestones.
Although the 28-day mortality for patients with respiratory failure did not differ between patients with and without respiratory syncytial virus (RSV), complications were more common in those with RSV.
The White House intends to nominate Monica Bertagnolli to run the National Institutes of Health (NIH); Supreme Court asks for more time to decide if mifepristone use will have more restrictions, and providers look to misoprostol as an alternative; House Republicans presented a proposal to require certain low-income Americans to work or risk losing Medicaid coverage.
Under the transaction, TPG, an asset management firm, will acquire a majority interest in OneOncology and AmerisourceBergen will have a minority interest; OneOncology physician leaders and practices will retain minority interests as well.
For all the success the hematology/oncology space has seen over the past 20-plus years, difficult discussions now focus on paying for that care, explained David A. Eagle, MD, New York Cancer & Blood Specialists.
In the first 2 years after receiving an HIV diagnosis, people with HIV were about 3 times more likely to develop depression, use antidepressants, and undergo electroconvulsive therapy—and 10 times more likely to commit suicide—compared with people without HIV.
New study data show that prescription patterns differed depending on the type of institution they were prescribed in and the specialty of prescribing physicians.
The practice is OneOncology's 16th partners overall and its first in Florida.
The data show how disease-modifying therapies are changing outcomes for children with spinal muscular atrophy (SMA), a rare neuromuscular disease.
Natalia Rost, MD, MPH, FAAN, FAHA, chief of the stroke division at Massachusetts General Hospital and chair of the American Academy of Neurology (AAN) Science Committee, previews the annual meeting and provides a glimpse into what the conference has to offer and its legacy of 75 years.
People 65 years and older and those with weakened immunity are eligible for additional COVID-19 boosters; some health insurers are beginning to cover telehealth abortion; apps are enticing nurses to take gig work beyond employees.
CMS in February 2023 announced 3 new models for testing by the Center for Medicare & Medicaid Innovation—all of which “aim to lower the cost of drugs, promote accessibility to life-changing drug therapies, and improve quality of care.”
David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, previews the American Academy of Neurology (AAN) annual meeting for 2023 and says that attendees can expect not only to learn but also to leave feeling humbled and inspired.
Adding motixafortide to standard stem cell mobilization therapy for autologous hematopoietic stem cell transplantation (ASCT) significantly improved collection success rates vs standard therapy plus a placebo in a phase 3 trial of patients with multiple myeloma.
